Sai Parenteral's

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0H9F01037
  • NSEID: SAIPARENT
  • BSEID: 544742
INR
582.00
10.65 (1.86%)
BSENSE

Jun 18

BSE+NSE Vol: 96.93 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

96.93 k (-37.42%) Volume

Shareholding (Apr 2026)

FII

5.73%

Held by 9 FIIs

DII

12.86%

Held by 3 DIIs

Promoter

51.16%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 2,571 Cr ()

stock-summary
P/E

176.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

5.10

Revenue and Profits:
Net Sales:
57 Cr
(Quarterly Results - Mar 2026)
Net Profit:
10 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

29-May-2026 | Source : BSE

Earnings Call Transcript

Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

28-May-2026 | Source : BSE

Receipt of Order

Announcement under Regulation 30 (LODR)-Investor Presentation

26-May-2026 | Source : BSE

Investor Presentation

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
1.90
Debt to EBITDA (avg)
8.61
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.46
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
18.59%
ROCE (avg)
5.37%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
176
Industry P/E
34
Price to Book Value
5.10
EV to EBIT
110.82
EV to EBITDA
62.57
EV to Capital Employed
5.95
EV to Sales
6.36
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.37%
ROE (Latest)
2.91%
Technicals key factors
Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
Bullish
OBV
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Apr 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (3.81%)

FIIs

Held by 9 FIIs (5.73%)

Promoter with highest holding

Vijitha Gorrepati (0.29%)

Highest Public shareholder

Quant Mutual Fund - Quant Small Cap Fund (0.038%)

Individual Investors Holdings

22.67%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "56.79",
          "val2": "38.48",
          "chgp": "47.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.22",
          "val2": "3.98",
          "chgp": "232.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.42",
          "val2": "2.12",
          "chgp": "61.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.95",
          "val2": "0.36",
          "chgp": "2,663.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.28%",
          "val2": "10.34%",
          "chgp": "12.94%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Sai Parenteral's"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Sai Parenteral's"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 30.56% vs 9.11% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 62.28% vs 44.41% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "162.25",
          "val2": "124.27",
          "chgp": "30.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.58",
          "val2": "26.95",
          "chgp": "13.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.77",
          "val2": "7.31",
          "chgp": "19.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "16.78",
          "val2": "10.34",
          "chgp": "62.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.85%",
          "val2": "21.69%",
          "chgp": "-2.84%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQstock-summary
Mar'26
Dec'25
Change(%)
Net Sales
56.79
38.48
47.58%
Operating Profit (PBDIT) excl Other Income
13.22
3.98
232.16%
Interest
3.42
2.12
61.32%
Exceptional Items
0.00
0.00
Standalone Net Profit
9.95
0.36
2,663.89%
Operating Profit Margin (Excl OI)
23.28%
10.34%
12.94%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'26stock-summary
Mar'26
Mar'25
Change(%)
Net Sales
162.25
124.27
30.56%
Operating Profit (PBDIT) excl Other Income
30.58
26.95
13.47%
Interest
8.77
7.31
19.97%
Exceptional Items
0.00
0.00
Standalone Net Profit
16.78
10.34
62.28%
Operating Profit Margin (Excl OI)
18.85%
21.69%
-2.84%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 30.56% vs 9.11% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 62.28% vs 44.41% in Mar 2025

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details